Literature DB >> 35690459

Current understanding of Hirschsprung-associated enterocolitis: Pathogenesis, diagnosis and treatment.

Ruth A Lewit1, Korah P Kuruvilla1, Ming Fu1, Ankush Gosain2.   

Abstract

Hirschsprung-associated enterocolitis (HAEC) was described in 1886 by Harald Hirschsprung and is a potentially deadly complication of Hirschsprung Disease. HAEC is classically characterized by abdominal distension, fever, and diarrhea, although there can be a variety of other associated symptoms, including colicky abdominal pain, lethargy, and the passage of blood-stained stools. HAEC occurs both pre-operatively and post-operatively, is the presenting symptom of HSCR in up to 25% of infants and varies in overall incidence from 20 to 60%. This article reviews our current understanding of HAEC pathogenesis, diagnosis, and treatment with discussion of areas of ongoing research, controversy, and future investigation.
Copyright © 2022. Published by Elsevier Inc.

Entities:  

Keywords:  Dysmotility; Enterocolitis; Hirschsprung disease; Microbiome; Mucosal immunity; Treatment

Mesh:

Year:  2022        PMID: 35690459      PMCID: PMC9523686          DOI: 10.1016/j.sempedsurg.2022.151162

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   1.900


  84 in total

Review 1.  Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung disease.

Authors:  J C Langer; M D Rollins; M Levitt; A Gosain; L de la Torre; R P Kapur; R A Cowles; J Horton; D H Rothstein; A M Goldstein
Journal:  Pediatr Surg Int       Date:  2017-02-08       Impact factor: 1.827

2.  Long-term follow-up of redo pull-through procedures for Hirschsprung's disease: efficacy of the endorectal pull-through.

Authors:  K van Leeuwen; D H Teitelbaum; E A Elhalaby; A G Coran
Journal:  J Pediatr Surg       Date:  2000-06       Impact factor: 2.545

3.  Resection margin histology may predict intermediate-term outcomes in children with rectosigmoid Hirschsprung disease.

Authors:  Lauren A Brooks; Kathryn L Fowler; Laura V Veras; Ming Fu; Ankush Gosain
Journal:  Pediatr Surg Int       Date:  2020-06-06       Impact factor: 1.827

4.  A decade of experience with the primary pull-through for hirschsprung disease in the newborn period: a multicenter analysis of outcomes.

Authors:  D H Teitelbaum; R E Cilley; N J Sherman; D Bliss; N D Uitvlugt; E J Renaud; I Kirstioglu; T Bengston; A G Coran
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

Review 5.  Hirschsprung's disease: what about mortality?

Authors:  Alessio Pini Prato; Valentina Rossi; Stefano Avanzini; Girolamo Mattioli; Nicola Disma; Vincenzo Jasonni
Journal:  Pediatr Surg Int       Date:  2011-05       Impact factor: 1.827

6.  Probiotics prevent Hirschsprung's disease-associated enterocolitis: a prospective multicenter randomized controlled trial.

Authors:  Xiaolin Wang; Zhi Li; Zhilin Xu; Zhongrong Wang; Jiexiong Feng
Journal:  Int J Colorectal Dis       Date:  2014-11-05       Impact factor: 2.571

7.  Bowel dysfunction following pullthrough surgery is associated with an overabundance of nitrergic neurons in Hirschsprung disease.

Authors:  Lily S Cheng; Dana M Schwartz; Ryo Hotta; Hannah K Graham; Allan M Goldstein
Journal:  J Pediatr Surg       Date:  2016-08-09       Impact factor: 2.545

8.  [Rectal irrigation and bowel decontamination for the prevention of postoperative enterocolitis in Hirschsprung's disease].

Authors:  R Núñez; A Torres; E Agulla; C Moreno; D Marín; J I Santamaría
Journal:  Cir Pediatr       Date:  2007-04

9.  A 40-year multinational retrospective study of 880 Swenson procedures.

Authors:  J O Sherman; M E Snyder; J J Weitzman; J Z Jona; D A Gillis; B O'Donnell; M Carcassonne; O Swenson
Journal:  J Pediatr Surg       Date:  1989-08       Impact factor: 2.545

10.  Enterocolitis after the surgical treatment of Hirschsprung's disease: risk factors and financial impact.

Authors:  D J Hackam; R M Filler; R H Pearl
Journal:  J Pediatr Surg       Date:  1998-06       Impact factor: 2.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.